Is a Smear Needed After Age 65 or After Menopause?

Published: 28 October 2026 · Medically reviewed by: Op. Dr. Murat Alpay

When can smear and HPV screening stop? The conditions at age 65, screening after menopause, women who have had a hysterectomy and those previously treated for cell changes.

Having reached menopause is not, by itself, a reason to stop smear screening. According to international guidelines, cervical cancer screening can end at age 65 in women whose recent screening results have been adequate and normal; but the decision rests on past results, not on age alone. For women who have never been screened or whose records are incomplete, stopping because "I am over 65" is wrong. This article explains when screening can stop, why a smear result can sometimes be misleading after menopause and how things change if the uterus has been removed. For the difference between the tests, see our page on the smear test and HPV test.

Conditions for Stopping at Age 65

In women at average risk, screening can end at age 65, but guidelines look for two conditions:

  • Adequate, normal previous screening: Consecutive normal results within the last 10 years, for example 3 normal smears in a row or 2 normal co-tests in a row (smear and HPV test done together). The most recent of these tests must have been done within the last 5 years.
  • No history of high-grade cell changes: No diagnosis of CIN 2, CIN 3 (moderate and advanced pre-cancerous cell changes) or adenocarcinoma in situ (pre-cancerous change in the glandular cells of the cervical canal) in the last 20 years, and no history of cervical cancer.

If these conditions are not met, screening continues after 65. The national program in Turkey recommends an HPV test every 5 years between ages 30 and 65; after 65 the decision is made with your doctor according to your past results. Intervals can vary by country and guideline.

Women Never Screened or Screened Incompletely

In women who reach 65 without ever having been screened, or whose records for the last 10 years are unknown, stopping screening is not correct. A significant share of cervical cancers are found in older women who were never screened or screened irregularly. In these women, screening is done at the first opportunity and follow-up continues until enough normal results are obtained.

Is a Smear Needed After Menopause?

Reaching menopause is not by itself a reason to stop screening. In postmenopausal women under 65, or over 65 with inadequate previous screening, the routine screening schedule for their age continues.

Why Can a Smear Result Be Misleading After Menopause?

After menopause, when the hormone estrogen falls, the tissue lining the vagina and cervix thins (atrophy). This affects the smear in two ways:

  • Mature surface cells decrease and small, deep cells (parabasal cells) become prominent. Because the nuclei of these cells look large, they can be confused with cell changes under the microscope and produce an "abnormal" result that is not really there (a false alarm).
  • Because the transition zone of the cervix is pulled up into the canal, collecting enough cells with the brush can be harder.

In this situation, the doctor may suspect that the screening result is due to thinning of the tissue and arrange further testing, or reassess the smear after the thinning has been treated. For tissue changes in menopause, see our article on genitourinary syndrome of menopause and, for how the result is read, our article on how to read a smear result.

Is a Smear Needed After a Hysterectomy?

The answer depends on the type and reason for the operation:

  • If the cervix was left in place (partial operation in which the body of the uterus is removed): The risk of cervical cancer continues, so routine screening for the person's age continues.
  • If the uterus and cervix were fully removed (total hysterectomy): If the operation was done for non-cancerous reasons such as fibroids, prolapse or bleeding, and there has been no CIN 2, CIN 3, adenocarcinoma in situ or cervical cancer in the last 20 years, screening ends after the operation; a vaginal smear is not needed.
  • If the operation was done for pre-cancerous change or cancer: Because the risk of cell changes at the site where the uterus was removed (the top of the vagina, the "vaginal cuff") continues, vaginal cuff smear screening continues for at least 20-25 years.

Women Previously Treated for Cell Changes

In women diagnosed with CIN 2, CIN 3 or adenocarcinoma in situ and treated (for example with procedures that remove part of the cervix), or whose cell change regressed on its own, the risk of recurrence and cancer stays high for many years. These women are therefore followed with routine or vaginal screening for at least 20-25 years from the date of treatment or regression, even if they pass 65 or have had a hysterectomy.

Outcomes of any surgical or interventional procedure vary from person to person. It is recommended that you get detailed advice from your doctor before the procedure.

For follow-up after cell changes, see our articles on abnormal smear results and follow-up of a positive HPV result.

Frequently Asked Questions

I have reached menopause. Can I stop having smears?

No, menopause alone is not a reason. The decision depends on your age and past results. If you are under 65, the screening schedule continues.

I am 65 and my last smear was 12 years ago. Is screening still needed?

Yes. If adequate normal results in the last 10 years cannot be documented, screening is done. Your doctor reviews your old results to decide.

My uterus was removed. Do I need to continue smears?

If the cervix was also removed, the operation was for a non-cancerous reason and there is no history of cell changes in the last 20 years, it is generally not needed. If the operation was for pre-cancerous change or cancer, vaginal screening continues for a long time.

My smear after menopause came back "abnormal." Is it cancer?

No; thinning of the tissue can make a change appear that is not really there. The doctor plans further testing; the result alone does not mean cancer.